STOCK TITAN

CoinShares director Daniel Masters sells shares

The October 14 weighted average sale price was $4.0293 per share, with reported trades ranging from $3.94 to $4.26.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

CoinShares PLC (CSHR) director and 10% owner Daniel Masters reported sales of ordinary shares on October 12–14, 2026, under a Rule 10b5-1 trading plan adopted June 12, 2026. He sold 20,000 shares at a weighted average price of $4.4607 per share on October 12, 20,000 at $4.3408 on October 13, and 32,978 at $4.0293 on October 14.

On October 12, he also exercised a call option covering 182,370 ordinary shares. The option had an aggregate exercise price of $238,959, equivalent to approximately $1.3103 per share. The reported underlying share count corrects a two-share overreport in an April 2, 2026 Form 4.

Insider Masters Daniel
Role Director, 10% Owner
Sold 72,978 shs ($309K)
Approx. gross sale proceeds $309K
Type Security Shares Price Value
Sale Ordinary Shares F2, F5 32,978 $4.0293 $133K
Sale Ordinary Shares F2, F4 20,000 $4.3408 $87K
In-the-Money Exercise Call Option (right to buy) F1, F6 1 $0.00 $0.00
In-the-Money Exercise Ordinary Shares F1 182,370 -- --
Sale Ordinary Shares F2, F3 20,000 $4.4607 $89K
Holdings After Transaction: Call Option (right to buy) — 0 contracts (Direct); Ordinary Shares — 21,619,637 shares (Direct)
Footnotes (6)
  1. F1. This option had an aggregate exercise price of $238,959 with respect to 182,370 ordinary shares underlying the option, equivalent to an exercise price of approximately $1.3103 per share.
  2. F2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026.
  3. F3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.41 to $4.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  4. F4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.26 to $4.465, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  5. F5. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.94 to $4.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  6. F6. The number of shares underlying this call option was inadvertently overreported by 2 shares in the Form 4 filed by the reporting person on April 2, 2026, and has been corrected here to reflect the actual number of shares underlying this call option.
Ordinary shares sold; weighted average price 20,000 shares; $4.4607 per share October 12, 2026
Ordinary shares sold; weighted average price 20,000 shares; $4.3408 per share October 13, 2026
Ordinary shares sold; weighted average price 32,978 shares; $4.0293 per share October 14, 2026
Ordinary shares underlying exercised call option 182,370 shares October 12, 2026
Aggregate exercise price $238,959 Call option covering 182,370 ordinary shares
Approximate exercise price per ordinary share Approximately $1.3103 per share Call option covering 182,370 ordinary shares
Rule 10b5-1 trading plan regulatory
"sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
aggregate exercise price financial
"This option had an aggregate exercise price of $238,959"
call option financial
"Call Option (right to buy)"
A call option is a contract that gives its buyer the right, but not the obligation, to buy a specific number of shares at a predetermined price within a set time period. Think of it as a refundable reservation to buy an item later at today’s price: you pay a fee up front and can profit if the stock rises, while your downside is limited to that fee; investors use calls to gain leverage, speculate on upside, or hedge positions without owning the shares.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CSHR shares did Daniel Masters sell, and at what prices?

Daniel Masters sold 20,000 ordinary shares on October 12, 2026, at a weighted average price of $4.4607 per share; 20,000 on October 13 at $4.3408; and 32,978 on October 14 at $4.0293. All three sales were made under a Rule 10b5-1 trading plan adopted June 12, 2026.

What happened to Daniel Masters's CSHR call option?

On October 12, 2026, Daniel Masters exercised a call option covering 182,370 ordinary shares. Its aggregate exercise price was $238,959, equivalent to approximately $1.3103 per share, and the reported option position following the transaction was zero. The underlying share count corrects a two-share overreport in an April 2, 2026 Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Masters Daniel

(Last)(First)(Middle)
C/O COINSHARES PLC, 2 HILL STREET

(Street)
ST HELIERJE2 4UA

(City)(State)(Zip)

JERSEY

(Country)
2. Issuer Name and Ticker or Trading Symbol
CoinShares PLC [ CSHR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/12/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares10/12/2026X182,370A(1)21,692,615D
Ordinary Shares10/12/2026S(2)20,000D$4.4607(3)21,672,615D
Ordinary Shares10/13/2026S(2)20,000D$4.3408(4)21,652,615D
Ordinary Shares10/14/2026S(2)32,978D$4.0293(5)21,619,637D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Call Option (right to buy)(1)10/12/2026X110/12/202610/12/2026Ordinary Shares182,370(6)$00D
Explanation of Responses:
1. This option had an aggregate exercise price of $238,959 with respect to 182,370 ordinary shares underlying the option, equivalent to an exercise price of approximately $1.3103 per share.
2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026.
3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.41 to $4.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.26 to $4.465, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
5. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.94 to $4.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
6. The number of shares underlying this call option was inadvertently overreported by 2 shares in the Form 4 filed by the reporting person on April 2, 2026, and has been corrected here to reflect the actual number of shares underlying this call option.
/s/ Daniel Masters10/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading